Finance

Lists
Why is CAMP down 7.09%?
Dive Deeper
CAMP:NASDAQ
CAMP4 Therapeutics Corp
$ 3.80
-7.09%
(-0.29) 1D
11-р сарын 13, 16:00:01 (GMT-5)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CAMP...
Open
$ 4.13
High
$ 4.13
Low
$ 3.75
Mkt. cap
238.47 сая
Avg. vol.
192.36 мян
Volume
46.16 мян
52-wk high
$ 7.75
52-wk low
$ 2.90
EPS
-$ 2.01
Shares outstanding
62.75 сая
No. of employees
48
Open
$ 4.13
High
$ 4.13
Low
$ 3.75
Mkt. cap
238.47 сая
Avg. vol.
192.36 мян
Volume
46.16 мян
52-wk high
$ 7.75
52-wk low
$ 2.90
EPS
-$ 2.01
Shares outstanding
62.75 сая
No. of employees
48
News stories
From web sources and news partners
About CAMP4 Therapeutics Corp
CEO-
Employees48
Founded2015
Headquarters-
SectorHealth Care
Industry-
Websitecamp4tx.com
Analyst ratings
Based on 8 analysts giving stock ratings to CAMP in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for CAMP in the last 3 months.
Highest
Current $ 3.80
$ 15.00 (+294.74%)
Average
$ 9.00 (+136.84%)
Lowest
$ 6.00 (+57.89%)
Analyst
Recommendation
Action
Price target
Projected
Date
Anupam Rama
J.P. Morgan
Buy
Maintained
$ 9.00
+136.8%
11/11/2026
Yun Zhong
Wedbush
Buy
Maintained
$ 8.00
+110.5%
11/06/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$ 7.00
+84.2%
11/05/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
$ 15.00
+294.7%
11/06/2026
Tiago Fauth
Raymond James
Buy
Initiated
$ 10.00
+163.2%
10/23/2026
Joseph Stringer
Needham
Buy
Initiated
$ 8.00
+110.5%
10/15/2026
Keay Nakae
Chardan Capital
Buy
Reiterated
$ 6.00
+57.9%
09/29/2026
Myles Minter
William Blair
Buy
Reiterated
-
-
09/29/2026
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
$ 7.00
+84.2%
04/14/2026
Mani Foroohar
Leerink Partners
Buy
Maintained
$ 9.00
+136.8%
04/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
2026 оны 9-р сар
Revenue
348.00 мян
1.29 сая
1.78 сая
1.90 сая
Cost of goods sold
8.36 сая
10.16 сая
10.82 сая
11.43 сая
Cost of revenue
8.36 сая
10.16 сая
10.82 сая
11.43 сая
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.77 сая
4.20 сая
4.34 сая
4.49 сая
Operating expense
4.77 сая
4.20 сая
4.34 сая
4.49 сая
Total operating expenses
13.12 сая
14.36 сая
15.16 сая
15.93 сая
Operating income
-12.78 сая
-13.07 сая
-13.38 сая
-14.03 сая
Other non operating income
-28.22 сая
-6.17 сая
-20.96 сая
-15.91 сая
EBT including unusual items
-40.28 сая
-18.33 сая
-33.53 сая
-28.96 сая
EBT excluding unusual items
-40.28 сая
-18.33 сая
-33.53 сая
-28.96 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-40.28 сая
-18.33 сая
-33.53 сая
-28.96 сая
Net profit margin
-11,575.86%
-1,416.62%
-1,884.77%
-1,524.80%
Earnings per share
-0.23
-0.21
-0.22
-0.17
Interest and investment income
716.00 мян
910.00 мян
807.00 мян
984.00 мян
Interest expense
-
-
-
-
Net interest expenses
716.00 мян
910.00 мян
807.00 мян
984.00 мян
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.40 сая
-12.55 сая
-12.86 сая
-13.51 сая
Gain or loss from assets sale
191.00 мян
-
-
98.00 мян
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google аппс